Safety of Prasugrel in Indian patients – Multicentric registry of 1000 cases

Safety of Prasugrel in Indian patients – Multicentric registry of 1000 cases

Background: Clopidogrel has been the only available antiplatelet drug used along with aspirin in patients of ACS. In recent years 2 new antiplatelet drugs (Prasugrel and Ticagrelor) have become available. Prasugrel in the dose of 10 mg OD has been found to be more efficacious but with increased risk...

Full description

Bibliographic Details
Main Authors: Upendra Kaul, Arvind Sethi, P. Arambam, A.K. Omar, R. Keshava, Sanjeeb Roy, Shuvanan Ray, Rakesh Jaswal, Ripan K. Gupta, Rakesh Rai Sapra, Rane Sandip Keshav, Rajpal Singh, Vineet Bhatia, Vinay Sanghi, Arun Chopra
Format: Article
Language:English
Published: Elsevier 2014-11-01
Series:Indian Heart Journal
Subjects:
Prasugrel
Bleeding
Safety
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483214007342

Internet

http://www.sciencedirect.com/science/article/pii/S0019483214007342

Similar Items